Anne Finucane

Insider profile

Currently holds a position at CVS Health Corporation

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director CVS Health Corporation Jan. 20, 2011 -
Anne Finucane's trades of Williams-Sonoma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
109.82
Quantity 69,610 +10.0%
Value US$3,447,806
Transaction date
Planned sale
Price
145.65
Quantity 78,995 +13.7%
Value US$2,405,948
Transaction date
Proposed sale
Price
378.63
Quantity 17,903
Value US$4,442,840
Transaction date
Proposed sale
Price
70.97
Quantity 7,500
Value US$532,275
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-16 2026-10-16
PlS Planned sale
69,610 +10.0%
109.82
US$3,447,806 		69,610 +10.0% 109.82 US$3,447,806
2026-10-16 2026-10-16
PlS Planned sale
78,995 +13.7%
145.65
US$2,405,948 		78,995 +13.7% 145.65 US$2,405,948
2026-10-16 2026-10-16
PrS Proposed sale
17,903
378.63
US$4,442,840 		17,903 378.63 US$4,442,840
2025-08-29 2025-08-20
S Sale
7,500 -25.3%
71.02
US$532,650 		7,500 -25.3% 71.02 US$532,650
2025-08-19 2025-08-20
PrS Proposed sale
7,500
70.97
US$532,275 		7,500 70.97 US$532,275